Skip to main content

Table 1 Baseline characteristics

From: Who benefits from orthogeriatric treatment? Results from the Trondheim hip-fracture trial

 

Geriatric

 

Orthopaedic

 

n = 198

n = 199

Age (years) - mean (SD)

83.4 (5.4)

83.2 (6.4)

Sex (female) - n (%)

145 (73.2)

148 (74.4)

Sheltered housing - n (%)

26 (13.5)

20 (10.3)

Living alone - n (%)

115 (58.1)

124 (62.3)

Barthel Index (0–20) - mean (SD)

18.3 (2.3)

18.1 (2.8)

NEAS (0–66) - mean (SD)

42.5 (17.7)

41.9 (17.5)

ASA score (1–5) mean (SD)

2.5 (0.7)

2.6 (0.7)

ASA score

1 or 2 (healthy or mild systemic disease) - n (%)

89 (45.0)

82 (41.2)

3 (severe systemic disease) - n (%)

103 (52.0)

106 (53.3)

4 or 5 (severe systemic disease or moribund) - n (%)

6 (3.0)

11 (5.5)

Previous diagnoses

Heart disease - n (%)

97 (49.0)

89 (44.7)

Stroke - n (%)

49 (24.7)

57 (28.6)

Diabetes - n (%)

23 (11.6)

28 (14.1)

Dementia - n (%)

27 (13.6)

26 (13.1)

Cancer - n (%)

53 (26.8)

43 (21.6)

Kidney disease - n (%)

18 (9.1)

9 (4.5)

Fracture type

Femoral neck - n (%)

119

(60.1)

127

(63.8)

Extra capsular fracture- n (%)

79

(39.9)

72

(36.1)

Surgery

Hemi prosthesis - n (%)

76

(38.4)

88

(44.2)

Bone plates and -screws - n (%)

69

(34.8)

63

(31.7)

Screws – n (%)

38

(19.2)

32

(16.1)

Othera- n (%)

15

(7.6)

16

(8.0)

  1. ASA American Society of Anaesthesiologists
  2. aIncluding patients treated with combinations of surgery or no surgery at all due to death